InsiderClue
← All stocks

Scholar Rock Holding Corp

SRRK Net selling
CIK 0001727196 #1156 in the set updated 17 Sep 2026
Bought (120 mo)
$84.71M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$173.86M
$39.46M on a plan · $34.49M straight out of an exercise
Sold at will
$99.91M
63 of 156 sales
Net
−$89.15M
−$15.20M against sales at will

By person

31 insiders · 188 transactions
141×

David Hallal holds 141 times base salary in stock. $90.09M of shares against $637.50K in salary for 2025.

Salary from the company's own proxy. The shares are what David Hallal last reported holding, valued at $54.96, the price Common Stock was last bought or sold at on the open market here, on 1 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Invus Public Equities, L.P.
10% owner
$17.55M (7)
$82.41M (7)
−$64.86M
9,250,005
7.60%
$508.42M
+5.7%
Myles Edward H
COO & CFO
—
$16.81M (19) scheduled
−$16.81M
111,345
0.0914%
$6.12M
−70.1%
Samsara BioCapital GP, LLC entity
10% owner
$15.00M (1)
—
+$15.00M
6,788,609
5.57%
$373.13M
+47.6%
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
—
$13.37M (24) scheduled
−$13.37M
98,445
0.0808%
$5.41M
−0.5%
Nashat Amir
Director
$7.87M (4)
—
+$7.87M
38,639
0.0317%
$2.12M
—
Artal International S.C.A.
10% owner
$6.30M (1)
—
+$6.30M
2,396,040
1.97%
$131.70M
—
Marantz Jing L.
CHIEF MEDICAL OFFICER
—
$4.06M (12) scheduled
−$4.06M
126,012
0.1035%
$6.93M
—
Hallal David
Chief Executive Officer
—
$3.97M (2)
−$3.97M
1,639,034
1.35%
$90.09M
+460.2%
Carven Gregory John
Chief Scientific Officer
—
$3.27M (8) scheduled
−$3.27M
128,208
0.1053%
$7.05M
+134.8%
FLIER JEFFREY S.
Director
—
$2.21M (13) scheduled
−$2.21M
27,856
0.0229%
$1.53M
−36.4%
Polaris Venture Management Co. VI, L.L.C. entity
10% owner
$2.00M (2)
—
+$2.00M
156,395
0.1284%
$8.60M
—
Backstrom Jay T.
CHIEF EXECUTIVE OFFICER
—
$1.85M (3)
−$1.85M
425,561
0.3494%
$23.39M
—
Ho Junlin
GENERAL COUNSEL
—
$1.82M (8)
−$1.82M
241,545
0.1983%
$13.28M
+525.2%
Vaishnaw Akshay
President of R&D
—
$1.68M (4)
−$1.68M
630,542
0.5177%
$34.66M
+6,569%
Parlavecchio Caryn
CHRO
—
$1.63M (11)
−$1.63M
169,087
0.1388%
$9.29M
+281.7%
Sacco Tracey
Chief Commercial Officer
—
$1.32M (7) scheduled
−$1.32M
71,750
0.0589%
$3.94M
—
Sinha Vikas
Chief Financial Officer
—
$1.23M (2)
−$1.23M
619,856
0.5090%
$34.07M
—
Woods Keith
Chief Operating Officer
—
$1.22M (2)
−$1.22M
620,055
0.5091%
$34.08M
—
SPRINGER TIMOTHY A
10% owner
$999.99K (1)
—
+$999.99K
2,376,567
1.95%
$130.63M
+64.5%
Gilman Michael
Director
—
$870.19K (10) scheduled
−$870.19K
59,511
0.0489%
$3.27M
+35.4%
AKKARAJU SRINIVAS
Director
$34.99M (10)
$34.39M (3) scheduled
+$603.31K
6,395,585
5.25%
$351.53M
+70.2%
Peng Katie
Director
—
$502.00K (10) scheduled
−$502.00K
34,301
0.0282%
$1.89M
—
Moore Erin
Interim PFO and PAO
—
$449.24K (1) scheduled
−$449.24K
82,609
0.0678%
$4.54M
0.0%
Burow Kristina
Director
—
$324.57K (4) scheduled
−$324.57K
2,460,368
2.02%
$135.23M
—
Reed Joshua
Director
—
$324.53K (4) scheduled
−$324.53K
19,518
0.0160%
$1.07M
—
Brudnick Richard
Director
—
$180.53K (2) scheduled
−$180.53K
21,896
0.0180%
$1.20M
—
Invus Global Management, LLC entity
10% owner
—
—
—
10,825,013
8.89%
$594.99M
+17.0%
ARCH Venture Fund VIII, L.P. entity
10% owner
—
—
—
2,637,617
2.17%
$144.97M
—
Mahanthappa Nagesh K.
Interim CEO and President
—
—
—
480,491
0.3945%
$26.41M
+26.3%
CHYUNG YUNG H.
Chief Medical Officer
—
—
—
258,496
0.2123%
$14.21M
+25.1%
Kingsley Stuart A
President and CEO
—
—
—
42,000
0.0345%
$2.31M
—

Individual transactions

188
Insider
Date
Role
Action
Shares
Price
Amount
Peng Katie
1 Jul 2026
Director
Sold on a plan
21
$54.96
$1.15K
Peng Katie
1 Jul 2026
Director
Sold on a plan
2,437
$54.25
$132.21K
Peng Katie
1 Jul 2026
Director
Sold on a plan
2,988
$53.56
$160.04K
Reed Joshua
1 Jul 2026
Director
Sold on a plan
948
$54.28
$51.46K
Reed Joshua
1 Jul 2026
Director
Sold on a plan
2,105
$53.50
$112.61K
Burow Kristina
1 Jul 2026
Director
Sold on a plan
948
$54.28
$51.46K
Burow Kristina
1 Jul 2026
Director
Sold on a plan
2,105
$53.49
$112.60K
Gilman Michael
1 Jul 2026
Director
Sold on a plan
43
$54.81
$2.36K
Gilman Michael
1 Jul 2026
Director
Sold on a plan
1,155
$54.23
$62.63K
Gilman Michael
1 Jul 2026
Director
Sold on a plan
1,346
$53.54
$72.07K
FLIER JEFFREY S.
1 Jul 2026
Director
Sold on a plan
15
$54.88
$823.14
FLIER JEFFREY S.
1 Jul 2026
Director
Sold on a plan
1,470
$54.24
$79.73K
FLIER JEFFREY S.
1 Jul 2026
Director
Sold on a plan
1,568
$53.53
$83.94K
Burow Kristina
23 Apr 2026
Director
Exercised, kept
18,000
$8.36
$150.48K
Burow Kristina
23 Apr 2026
Director
Exercised, kept
36,000
$9.11
$327.96K
Burow Kristina
23 Apr 2026
Director
Exercised, kept
28,000
$4.75
$133.00K
Burow Kristina
23 Apr 2026
Director
Exercised, kept
7,800
$26.78
$208.88K
Hallal David
16 Apr 2026
Chief Executive Officer
Sell
30,615
$49.57
$1.52M
Sinha Vikas
16 Apr 2026
Chief Financial Officer
Sell
10,410
$49.57
$516.07K
Vaishnaw Akshay
16 Apr 2026
President of R&D
Sell
12,246
$49.57
$607.09K
Woods Keith
16 Apr 2026
Chief Operating Officer
Sell
10,220
$49.57
$506.65K
Qatanani Mo
23 Feb 2026
CHIEF SCIENTIFIC OFFICER
Sold on a plan
200
$48.48
$9.70K
Qatanani Mo
23 Feb 2026
CHIEF SCIENTIFIC OFFICER
Sold on a plan
857
$47.86
$41.01K
Qatanani Mo
23 Feb 2026
CHIEF SCIENTIFIC OFFICER
Sold on a plan
7,427
$46.94
$348.64K
Qatanani Mo
17 Feb 2026
CHIEF SCIENTIFIC OFFICER
Sell
7,989
$46.53
$371.71K
Parlavecchio Caryn
17 Feb 2026
CHRO
Sell
9,035
$46.53
$420.38K
Ho Junlin
17 Feb 2026
GENERAL COUNSEL
Sell
9,580
$46.53
$445.74K
Marantz Jing L.
17 Feb 2026
CHIEF MEDICAL OFFICER
Sell
4,157
$46.53
$193.42K
Qatanani Mo
22 Jan 2026
CHIEF SCIENTIFIC OFFICER
Sold on a plan
12,779
$46.85
$598.75K
Qatanani Mo
22 Jan 2026
CHIEF SCIENTIFIC OFFICER
Sold on a plan
2,119
$45.87
$97.19K
Ho Junlin
16 Jan 2026
GENERAL COUNSEL
Sell
8,016
$44.48
$356.53K
Marantz Jing L.
16 Jan 2026
CHIEF MEDICAL OFFICER
Sell
5,798
$44.48
$257.88K
Parlavecchio Caryn
16 Jan 2026
CHRO
Sell
6,600
$44.48
$293.55K
Qatanani Mo
16 Jan 2026
CHIEF SCIENTIFIC OFFICER
Sell
8,406
$44.48
$373.88K
Qatanani Mo
14 Jan 2026
CHIEF SCIENTIFIC OFFICER
Sold after exercise
13,112
$45.20
$592.61K
Hallal David
13 Jan 2026
Chief Executive Officer
Sell
57,450
$42.70
$2.45M
Vaishnaw Akshay
13 Jan 2026
President of R&D
Sell
20,438
$42.70
$872.70K
Woods Keith
13 Jan 2026
Chief Operating Officer
Sell
16,746
$42.70
$715.05K
Sinha Vikas
13 Jan 2026
Chief Financial Officer
Sell
16,755
$42.70
$715.44K
Peng Katie
16 Dec 2025
Director
Sold on a plan
280
$44.63
$12.50K
Peng Katie
16 Dec 2025
Director
Sold on a plan
726
$43.88
$31.85K
AKKARAJU SRINIVAS
12 Dec 2025
Director
Exercised, kept indirect
1,064,804
$7.35
$7.83M
Invus Global Management, LLC
11 Dec 2025
10% owner
Exercised, kept
1,575,008
$7.35
$11.58M
Qatanani Mo
4 Dec 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
136,462
$45.21
$6.17M
AKKARAJU SRINIVAS
7 Oct 2025
Director
Buy indirect
4,403
$40.97
$180.39K
AKKARAJU SRINIVAS
7 Oct 2025
Director
Buy indirect
12,400
$40.18
$498.23K
AKKARAJU SRINIVAS
7 Oct 2025
Director
Buy indirect
12,796
$39.31
$503.01K
AKKARAJU SRINIVAS
6 Oct 2025
Director
Buy indirect
13,748
$39.52
$543.32K
AKKARAJU SRINIVAS
6 Oct 2025
Director
Buy indirect
80,863
$38.68
$3.13M
AKKARAJU SRINIVAS
6 Oct 2025
Director
Buy indirect
18,414
$37.89
$697.71K
AKKARAJU SRINIVAS
3 Oct 2025
Director
Buy indirect
319,700
$37.42
$11.96M
AKKARAJU SRINIVAS
3 Oct 2025
Director
Buy indirect
56,703
$36.74
$2.08M
AKKARAJU SRINIVAS
3 Oct 2025
Director
Buy indirect
11,011
$35.61
$392.10K
Qatanani Mo
22 Sep 2025
CHIEF SCIENTIFIC OFFICER
Sell
3,353
$30.67
$102.85K
Qatanani Mo
16 Sep 2025
CHIEF SCIENTIFIC OFFICER
Sell
3,178
$33.52
$106.53K
Peng Katie
16 Sep 2025
Director
Sold on a plan
76
$33.20
$2.52K
Peng Katie
16 Sep 2025
Director
Sold on a plan
930
$32.48
$30.20K
Parlavecchio Caryn
18 Aug 2025
CHRO
Sell
2,178
$31.17
$67.88K
FLIER JEFFREY S.
16 Jul 2025
Director
Sold on a plan indirect
11,136
$40.02
$445.69K
Qatanani Mo
8 Jul 2025
CHIEF SCIENTIFIC OFFICER
Sold on a plan
24,066
$34.44
$828.90K
FLIER JEFFREY S.
23 Jun 2025
Director
Sold after exercise indirect
11,136
$33.21
$369.82K
FLIER JEFFREY S.
23 Jun 2025
Director
Sold after exercise
2,766
$32.74
$90.55K
FLIER JEFFREY S.
23 Jun 2025
Director
Sold after exercise
17,550
$32.16
$564.36K
Ho Junlin
16 Jun 2025
GENERAL COUNSEL
Sell
7,442
$32.00
$238.15K
Parlavecchio Caryn
16 Jun 2025
CHRO
Sell
6,186
$32.00
$197.96K
Qatanani Mo
16 Jun 2025
CHIEF SCIENTIFIC OFFICER
Sell
3,668
$32.00
$117.38K
Peng Katie
16 Jun 2025
Director
Sold on a plan
54
$32.53
$1.76K
Peng Katie
16 Jun 2025
Director
Sold on a plan
2,977
$31.96
$95.13K
Vaishnaw Akshay
29 May 2025
President of R&D
Sold on a plan
1,620
$30.01
$48.61K
Vaishnaw Akshay
29 May 2025
President of R&D
Sold on a plan
5,130
$29.63
$152.00K
Reed Joshua
29 May 2025
Director
Sold on a plan
500
$30.04
$15.02K
Reed Joshua
29 May 2025
Director
Sold on a plan
4,900
$29.68
$145.44K
Brudnick Richard
29 May 2025
Director
Sold on a plan
1,400
$30.00
$42.00K
Brudnick Richard
29 May 2025
Director
Sold on a plan
4,675
$29.63
$138.53K
Gilman Michael
29 May 2025
Director
Sold on a plan
2,745
$29.83
$81.90K
Gilman Michael
29 May 2025
Director
Sold on a plan
630
$29.22
$18.41K
Burow Kristina
29 May 2025
Director
Sold on a plan
4,400
$29.83
$131.27K
Burow Kristina
29 May 2025
Director
Sold on a plan
1,000
$29.24
$29.24K
FLIER JEFFREY S.
29 May 2025
Director
Sold on a plan
4,975
$29.84
$148.43K
FLIER JEFFREY S.
29 May 2025
Director
Sold on a plan
1,100
$29.23
$32.15K
Sacco Tracey
25 Apr 2025
Chief Commercial Officer
Sold after exercise
84
$33.49
$2.81K
Sacco Tracey
25 Apr 2025
Chief Commercial Officer
Sold after exercise
4,916
$32.81
$161.32K
Moore Erin
24 Mar 2025
Interim PFO and PAO
Sold after exercise
13,564
$33.12
$449.24K
Sacco Tracey
24 Mar 2025
Chief Commercial Officer
Sold after exercise
5,000
$32.89
$164.46K
Sacco Tracey
24 Mar 2025
Chief Commercial Officer
Sold after exercise
1,500
$33.70
$50.56K
Peng Katie
17 Mar 2025
Director
Sold on a plan
1,006
$34.42
$34.63K
Myles Edward H
10 Mar 2025
COO & CFO
Sold after exercise
29,395
$34.87
$1.03M
Myles Edward H
10 Mar 2025
COO & CFO
Sold after exercise
112,897
$35.82
$4.04M
Qatanani Mo
19 Feb 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
20,202
$37.74
$762.50K
Qatanani Mo
19 Feb 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
8,341
$37.56
$313.29K
Qatanani Mo
19 Feb 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
39,967
$37.20
$1.49M
Backstrom Jay T.
18 Feb 2025
CHIEF EXECUTIVE OFFICER
Sell
18,372
$36.83
$676.62K
Ho Junlin
18 Feb 2025
GENERAL COUNSEL
Sell
5,742
$36.83
$211.47K
Myles Edward H
18 Feb 2025
COO & CFO
Sell
7,809
$36.83
$287.60K
Parlavecchio Caryn
18 Feb 2025
CHRO
Sell
5,296
$36.83
$195.05K
Qatanani Mo
18 Feb 2025
CHIEF SCIENTIFIC OFFICER
Sold on a plan
4,135
$36.83
$152.29K
Ho Junlin
16 Jan 2025
GENERAL COUNSEL
Sell
9,039
$44.20
$399.50K
Myles Edward H
16 Jan 2025
COO & CFO
Sell
12,539
$44.20
$554.19K
Parlavecchio Caryn
16 Jan 2025
CHRO
Sell
6,434
$44.20
$284.36K
Qatanani Mo
16 Jan 2025
CHIEF SCIENTIFIC OFFICER
Sell
7,347
$44.20
$324.72K
Sacco Tracey
16 Jan 2025
Chief Commercial Officer
Sell
3,890
$44.20
$171.93K
Marantz Jing L.
16 Jan 2025
CHIEF MEDICAL OFFICER
Sell
5,655
$44.20
$249.94K
Backstrom Jay T.
16 Jan 2025
CHIEF EXECUTIVE OFFICER
Sell
22,308
$44.20
$985.95K
Invus Public Equities, L.P.
10 Dec 2024
10% owner
Sell
1,600,000
$41.65
$66.64M
Marantz Jing L.
25 Nov 2024
CHIEF MEDICAL OFFICER
Sold after exercise
200
$40.72
$8.14K
Marantz Jing L.
25 Nov 2024
CHIEF MEDICAL OFFICER
Sold after exercise
3,075
$39.93
$122.78K
Marantz Jing L.
25 Nov 2024
CHIEF MEDICAL OFFICER
Sold after exercise
2,100
$39.25
$82.43K
Marantz Jing L.
25 Nov 2024
CHIEF MEDICAL OFFICER
Sold after exercise
1,000
$38.04
$38.04K
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
149
$40.98
$6.11K
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
30,683
$40.14
$1.23M
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
126,442
$39.51
$5.00M
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
43,887
$38.43
$1.69M
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
208,272
$37.63
$7.84M
Marantz Jing L.
22 Nov 2024
CHIEF MEDICAL OFFICER
Sold after exercise
2,145
$30.01
$64.37K
Marantz Jing L.
11 Nov 2024
CHIEF MEDICAL OFFICER
Sold after exercise
2,105
$30.00
$63.16K
Myles Edward H
8 Oct 2024
COO & CFO
Sold after exercise
37,187
$34.90
$1.30M
Marantz Jing L.
7 Oct 2024
CHIEF MEDICAL OFFICER
Sold after exercise
39,375
$30.06
$1.18M
Marantz Jing L.
7 Oct 2024
CHIEF MEDICAL OFFICER
Sold after exercise
2,552
$26.22
$66.92K
Marantz Jing L.
7 Oct 2024
CHIEF MEDICAL OFFICER
Sold after exercise
67,448
$25.59
$1.73M
AKKARAJU SRINIVAS
7 Oct 2024
Director
Sold on a plan indirect
155,713
$32.50
$5.06M
AKKARAJU SRINIVAS
7 Oct 2024
Director
Sold on a plan indirect
510,000
$30.00
$15.30M
AKKARAJU SRINIVAS
7 Oct 2024
Director
Sold on a plan indirect
510,000
$27.50
$14.03M
Sacco Tracey
7 Oct 2024
CHIEF COMMERCIAL OFFICER
Sold after exercise
1,964
$26.23
$51.52K
Sacco Tracey
7 Oct 2024
CHIEF COMMERCIAL OFFICER
Sold after exercise
28,036
$25.58
$717.16K
Myles Edward H
7 Oct 2024
COO & CFO
Sold after exercise
31,250
$29.05
$907.81K
Myles Edward H
7 Oct 2024
COO & CFO
Sold after exercise
25,812
$27.27
$703.89K
Myles Edward H
7 Oct 2024
COO & CFO
Sold after exercise
37,206
$26.83
$998.24K
Myles Edward H
7 Oct 2024
COO & CFO
Sold after exercise
111,972
$25.61
$2.87M
Qatanani Mo
16 Sep 2024
CHIEF SCIENTIFIC OFFICER
Sell
1,936
$8.58
$16.61K
Parlavecchio Caryn
16 Aug 2024
CHRO
Sell
1,451
$9.33
$13.54K
Ho Junlin
17 Jun 2024
GENERAL COUNSEL
Sell
4,695
$8.98
$42.18K
Myles Edward H
17 Jun 2024
COO & CFO
Sell
9,458
$8.98
$84.98K
Parlavecchio Caryn
17 Jun 2024
CHRO
Sell
4,305
$8.98
$38.68K
Qatanani Mo
17 Jun 2024
CHIEF SCIENTIFIC OFFICER
Sell
2,315
$8.99
$20.80K
Backstrom Jay T.
16 Feb 2024
CHIEF EXECUTIVE OFFICER
Sell
11,614
$15.74
$182.84K
Ho Junlin
16 Feb 2024
GENERAL COUNSEL
Sell
3,489
$15.74
$54.93K
Parlavecchio Caryn
16 Feb 2024
CHRO
Sell
3,751
$15.74
$59.05K
Qatanani Mo
16 Feb 2024
CHIEF SCIENTIFIC OFFICER
Sell
2,512
$15.74
$39.55K
Myles Edward H
16 Feb 2024
COO & CFO
Sell
4,744
$15.74
$74.69K
Ho Junlin
16 Jan 2024
GENERAL COUNSEL
Sell
4,186
$15.93
$66.68K
Myles Edward H
16 Jan 2024
COO & CFO
Sell
6,634
$15.93
$105.67K
Parlavecchio Caryn
16 Jan 2024
CHRO
Sell
2,849
$15.93
$45.38K
Qatanani Mo
16 Jan 2024
SVP AND HEAD OF RESEARCH
Sell
2,002
$15.93
$31.89K
Myles Edward H
29 Dec 2023
COO & CFO
Sold after exercise
300
$19.51
$5.85K
Myles Edward H
29 Dec 2023
COO & CFO
Sold after exercise
12,159
$18.82
$228.78K
Qatanani Mo
14 Dec 2023
SVP AND HEAD OF RESEARCH
Sold after exercise
24,662
$18.18
$448.44K
Myles Edward H
7 Dec 2023
COO & CFO
Sold after exercise
24,914
$17.53
$436.82K
Myles Edward H
2 Nov 2023
COO & CFO
Sold on a plan
35,007
$12.51
$438.04K
Samsara BioCapital GP, LLC
16 Oct 2023
10% owner
Buy indirect
2,189,781
$6.85
$15.00M
AKKARAJU SRINIVAS
16 Oct 2023
Director
Buy indirect
2,189,781
$6.85
$15.00M
Invus Public Equities, L.P.
12 Oct 2023
10% owner
Buy
10,150
$8.55
$86.74K
Invus Public Equities, L.P.
12 Oct 2023
10% owner
Buy
2,189,781
$6.85
$15.00M
Qatanani Mo
18 Sep 2023
SVP AND HEAD OF RESEARCH
Sell
1,945
$6.34
$12.33K
Parlavecchio Caryn
16 Aug 2023
CHRO
Sell
1,353
$6.83
$9.24K
Invus Public Equities, L.P.
28 Apr 2023
10% owner
Buy
31,557
$6.43
$202.85K
Invus Public Equities, L.P.
9 Jan 2023
10% owner
Sell
1,094
$9.48
$10.37K
Invus Public Equities, L.P.
5 Jan 2023
10% owner
Buy
48,774
$9.33
$455.09K
Invus Public Equities, L.P.
25 Oct 2022
10% owner
Buy
130,265
$8.04
$1.05M
Invus Public Equities, L.P.
4 Oct 2022
10% owner
Buy
66,000
$7.89
$520.76K
Invus Public Equities, L.P.
3 Oct 2022
10% owner
Buy
33,971
$7.03
$238.79K
Nashat Amir
22 Jun 2022
Director
Buy indirect
66,142
$4.90
$324.10K
Nashat Amir
22 Jun 2022
Director
Buy indirect
1,131,850
$4.90
$5.55M
Myles Edward H
15 Nov 2021
Chief Financial Officer
Sold after exercise
4,879
$35.05
$171.01K
Myles Edward H
12 Nov 2021
Chief Financial Officer
Sold after exercise
49,848
$35.12
$1.75M
Myles Edward H
11 Nov 2021
Chief Financial Officer
Sold after exercise
23,574
$35.20
$829.86K
FLIER JEFFREY S.
1 Oct 2021
Director
Sell indirect
6,000
$30.89
$185.33K
FLIER JEFFREY S.
20 Sep 2021
Director
Sell
500
$34.09
$17.05K
FLIER JEFFREY S.
26 Jul 2021
Director
Sell indirect
3,037
$31.48
$95.61K
FLIER JEFFREY S.
26 Jul 2021
Director
Sell indirect
2,963
$31.84
$94.35K
Gilman Michael
15 Mar 2021
Director
Sell
4,696
$65.59
$308.00K
Gilman Michael
8 Feb 2021
Director
Sell
1,804
$65.06
$117.36K
Carven Gregory John
27 Jan 2021
Head of Research
Sold after exercise
1,561
$57.79
$90.21K
Carven Gregory John
27 Jan 2021
Head of Research
Sold after exercise
12,139
$56.72
$688.51K
Carven Gregory John
27 Jan 2021
Head of Research
Sold after exercise
5,400
$55.87
$301.68K
Carven Gregory John
26 Jan 2021
Head of Research
Sold after exercise
1,064
$61.52
$65.45K
Carven Gregory John
26 Jan 2021
Head of Research
Sold after exercise
8,417
$60.65
$510.49K
Carven Gregory John
26 Jan 2021
Head of Research
Sold after exercise
9,249
$59.69
$552.10K
Carven Gregory John
26 Jan 2021
Head of Research
Sold after exercise
13,368
$58.79
$785.97K
Carven Gregory John
26 Jan 2021
Head of Research
Sold after exercise
4,676
$57.91
$270.81K
Gilman Michael
26 Jan 2021
Director
Sold after exercise
1,518
$59.90
$90.93K
Gilman Michael
26 Jan 2021
Director
Sold after exercise
1,500
$59.02
$88.53K
Gilman Michael
26 Jan 2021
Director
Sold after exercise
483
$57.99
$28.01K
SPRINGER TIMOTHY A
29 May 2018
Director
Buy
71,428
$14.00
$999.99K
Artal International S.C.A.
29 May 2018
10% owner
Buy indirect
450,000
$14.00
$6.30M
Nashat Amir
29 May 2018
Director
Buy indirect
7,887
$14.00
$110.42K
Nashat Amir
29 May 2018
Director
Buy indirect
134,970
$14.00
$1.89M
Polaris Venture Management Co. VI, L.L.C.
29 May 2018
10% owner
Buy indirect
7,887
$14.00
$110.42K
Polaris Venture Management Co. VI, L.L.C.
29 May 2018
10% owner
Buy indirect
134,970
$14.00
$1.89M

What was left out

Form 4 filings counted 279
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 44
Sales straight out of an exercise 49
Sales at will 63
Transactions with no price 0
Shares from compensation/vesting 30,368,050
Sales filed before the plan box existed 7
History held since 31 May 2018